Trial-based cost-effectiveness analysis of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus DSAEK

被引:5
|
作者
Simons, Rob W. P. [1 ]
Dickman, Mor M. [1 ]
van den Biggelaar, Frank J. H. M. [1 ]
Dirksen, Carmen D. [2 ]
Van Rooij, Jeroen [3 ]
Remeijer, Lies [3 ]
Van der Lelij, Allegonda [4 ,5 ]
Wijdh, Robert H. J. [6 ]
Kruit, Pieter J. [7 ]
Nuijts, Rudy M. M. A. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Univ Eye Clin Maastricht, POB 5800, NL-6202 AZ Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands
[3] Rotterdam Eye Hosp, Rotterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands
[5] Cent Mil Hosp, Dept Ophthalmol, Utrecht, Netherlands
[6] Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands
[7] Euro Tissue Bank, Beverwijk, Netherlands
关键词
corneal transplantation; cost-effectiveness; costs; Descemet stripping automated endothelial keratoplasty; Fuchs' endothelial dystrophy; quality-adjusted life years; ultrathin Descemet stripping automated endothelial keratoplasty; POSTERIOR LAMELLAR KERATOPLASTY; PENETRATING KERATOPLASTY; OUTCOMES;
D O I
10.1111/aos.14126
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To evaluate the cost-effectiveness of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus standard DSAEK. Methods A cost-effectiveness analysis using data from a multicentre randomized clinical trial was performed. The time horizon was 12 months postoperatively. Sixty-four eyes of 64 patients with Fuchs' endothelial dystrophy were included and randomized to UT-DSAEK (n = 33) or DSAEK (n = 31). Relevant resources from healthcare and societal perspectives were included in the cost analysis. Quality-adjusted life years (QALYs) were determined using the Health Utilities Index Mark 3 questionnaire. The main outcome was the incremental cost-effectiveness ratio (ICER; incremental societal costs per QALY). Results Societal costs were euro9431 (US$11 586) for UT-DSAEK and euro9110 (US$11 192) for DSAEK. Quality-adjusted life years (QALYs) were 0.74 in both groups. The ICER indicated inferiority of UT-DSAEK. The cost-effectiveness probability ranged from 37% to 42%, assuming the maximum acceptable ICER ranged from euro2500-euro80 000 (US$3071-US$98 280) per QALY. Additional analyses were performed omitting one UT-DSAEK patient who required a regraft [ICER euro9057 (US$11 127) per QALY, cost-effectiveness probability: 44-62%] and correcting QALYs for an imbalance in baseline utilities [ICER euro23 827 (US$29 271) per QALY, cost-effectiveness probability: 36-59%]. Furthermore, the ICER was euro2101 (US$2581) per patient with clinical improvement in best spectacle-corrected visual acuity (>= 0.2 logMAR) and euro3274 (US$4022) per patient with clinical improvement in National Eye Institute Visual Functioning Questionnaire-25 composite score (>= 10 points). Conclusion The base case analysis favoured DSAEK, since costs of UT-DSAEK were higher while QALYs were comparable. However, additional analyses revealed no preference for UT-DSAEK or DSAEK. Further cost-effectiveness studies are required to reduce uncertainty.
引用
收藏
页码:756 / 763
页数:8
相关论文
共 50 条
  • [21] Posteriore lamelläre Keratoplastik (DSAEK)Descemet’s stripping automated endothelial keratoplasty (DSAEK)
    C. Cursiefen
    F.E. Kruse
    Der Ophthalmologe, 2009, 106 : 939 - 954
  • [22] Double Descemet Stripping Automated Endothelial Keratoplasty (DSAEK): Secondary DSAEK Without Removal of the Failed Primary DSAEK Graft
    Kim, Ryan S.
    Kim, Gene
    OPHTHALMOLOGY, 2019, 126 (09) : 1218 - 1218
  • [23] Prevention and management of complications in descemet membrane endothelial keratoplasty (DMEK) and descemet stripping automated endothelial keratoplasty (DSAEK) [Komplikationsvermeidung und -management bei "descemet membrane endothelial keratoplasty" (DMEK) und "descemet stripping automated endothelial keratoplasty" (DSAEK)]
    Cursiefen C.
    Steven P.
    Roters S.
    Heindl L.M.
    Der Ophthalmologe, 2013, 110 (7): : 614 - 621
  • [24] Prevention and management of complications in Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping automated endothelial keratoplasty (DSAEK)
    Cursiefen, C.
    Steven, P.
    Roters, S.
    Heindl, L. M.
    OPHTHALMOLOGE, 2013, 110 (07): : 614 - +
  • [25] Histologically proven epithelial ingrowth in failed Descemet stripping automated endothelial keratoplasty (DSAEK) managed by repeat DSAEK
    Ghosh, Saurabh
    Bonshek, Richard
    Morgan, Stephen J.
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1035 - 1039
  • [26] Immunreaktion mit Khodadoust-Linie nach ‚‚Descemet stripping automated endothelial keratoplasty’‘ (DSAEK)Immunological graft rejection with Khodadoust line after “Descemet stripping automated endothelial keratoplasty” (DSAEK)
    M. Fiorentzis
    A. Viestenz
    B. Seitz
    Der Ophthalmologe, 2015, 112 : 783 - 787
  • [27] Subconjunctival Emphysema After Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)
    Ide, Takeshi
    Kymionis, George D.
    Yoo, Sonia H.
    O'Brien, Terrence P.
    OPEN OPHTHALMOLOGY JOURNAL, 2008, 2 : 107 - 108
  • [28] Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure (Review)
    Stuart, Alastair J.
    Romano, Vito
    Virgili, Gianni
    Shortt, Alex J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (06):
  • [29] Comparison of the Visual Outcomes of Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) and Penetrating Keratoplasty
    Chikama, T. -I.
    Sato, Y.
    Morita, Y.
    Yanai, R.
    Yamada, N.
    Morishige, N.
    Nishida, T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [30] Visual quality assessment after DSAEK corneal keratoplasty (Descemet Stripping Automated Endothelial Keratoplasty)
    Guechi, Oualid
    Boiche, Mathilde
    Yahia, Rekia
    Ghetemme, Cedric
    Houmad, Naila
    Baudot, Audrey
    Ameloot, Francois
    Perone, Jean-Marc
    Bertaux, Pierre-jean
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)